Prot #CA212001: A Phase 1, Open-label, Multicenter Study of BMS-936564 (MDX-1338) in Subjects with Relapsed Acute Myelogenous Leukemia and selected B-cell malignancies

Project: Research project

Project Details

StatusFinished
Effective start/end date7/15/13 → 7/15/19

Funding

  • Bristol-Myers Squibb Company (Prot #CA212001)